Allied Market Research
Loading...
0
2021
U.s. Topical Pain Relief Market

U.S. Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), and Distribution Channel (Pharmacies & Drug Stores, E-Commerce, and Retail & Grocery Stores): Opportunity Analysis and Industry Forecast, 2020–2027

A04993
Pages: 128
Jan 2021 | 10091 Views
   
Author(s) : Sagar Mukhekar, Sushant Terdale , Onkar Sumant
Tables: 37
Charts: 49
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the U.s. Topical Pain Relief Market

Request Now !

The U.S. topical pain relief market was valued at $2,612 million in 2019, and is projected to reach $3,272 million by 2027 at a CAGR of 3.7% from 2020 to 2027. 

Topical pain relief medications are applied directly to the epidermal layer of the skin at the area of inflammation or pain. Topical pain relief products are designed to relieve pain and utilize skin as the vehicle for drug administration and exert major action at the targeted site & in the central nervous system. These formulations are analgesic or anesthetic agents which are applied on or around the painful site. The aim is to offer a slow and gradual release of pain relief medication into the bloodstream by keeping the blood levels relatively constant for a certain period of time. These medications offer lesser side effects as compared to oral medications. Topical pain relievers include the administration of non-opioids and opioids drugs. Non-opioids drugs include nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylates, capsaicin, lidocaine, and other non-opioids. Opioids drugs include buprenorphine and fentanyl.

US-Topical-Pain-Relief-Market-2020-2027

Get more information on this report : Request Sample Pages

The growth of the U.S. topical pain relief market is majorly driven by increase in prevalence of arthritis and other bone-related conditions, diabetic neuropathy, leading to pain. Other factors that boost the U.S. topical pain relief market growth include rise in adoption of topical pain relief products as they cause lesser side effects as compared to oral pain relief, upsurge in geriatric population across the U.S., and increase in demand for topical pain relief by sports players. However, factors such as topical pain relief medications can cause irritated skin and they have a strong odor or unpleasant smell that hamper the market growth. Conversely, the development of online platform for the topical therapeutics is expected to provide lucrative growth opportunities for the market.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Nationwide lockdown, government regulations, and continuous increase in infection rate across the country created a widespread financial impact on clinics and pain services. Large number of clinics and pain services has witnessed a drop in number of patient visits amid COVID-19 ultimately reducing client contact. Moreover, most chronic pain facilities were deemed non-urgent, both outpatient and elective interventional procedures were limited or stopped during the COVID-19 pandemic to minimize risk of the viral spread. Thus, a negative impact of COVID-19 on opioids topical pain relief market is observed.

U.s. Topical Pain Relief Market Segmentation  

The U.S. topical pain relief market is segmented into therapeutic class, type, formulation, and distribution channel. On the basis of therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioids segment is further divided into nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, capsaicin, lidocaine, and other non-opioids. The opioids segment is further bifurcated into buprenorphine and fentanyl. On the basis of type, the market is segmented into prescription pain relief and over-the-counter (OTC) relief. On the basis of formulation, the market is classified into cream, gel, spray, patch, and others. The distribution channels covered in the study include pharmacies & drug stores, e-commerce, and retail & grocery stores.

U.S. Topical Pain Relief Market
By Therapeutic Class

Your browser does not support the canvas element.

Non-Opioids segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment review 

Presently, on the basis of therapeutic class, non-opioids segment is the major revenue contributor, and is projected to grow significantly during the forecast period due to its preferable use over the opioid drugs for treatment of mild to moderate pain. Due to less side effects as compared to opioids and no substance abuse, non-opioids are the preferred choice for the treatment of pain. However, due to restricted analgesic effects of the non-opioid drugs, their use is limited for the treatment of severe pain. 

Increase in awareness regarding adverse effects of non-opioids, surge in number of geriatric population, growth in number of patients with chronic pain, rise in prevalence of arthritis and other joint problems, majorly drive the growth of this segment. Arthritis is one of the most common and widely spread disorder that affects millions of people in the U.S. According to Centers for Disease Control and Prevention data, approximately 22.8% of total adult population was affected by arthritis in 2017.

According to distribution channel, the market is classified into pharmacies & drug stores, e-commerce, and retail & grocery stores. The e-commerce segment is anticipated to depict significant growth during the forecast period due to rise in preference for online purchase of drugs over the traditional methods, increase in awareness of online pharmacy, and rise in number of internet users. 

The key players profiled in this report include Advacare Pharma, Glaxosmithkline Plc (GSK), Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi, Sun Pharmaceutical Industries Ltd., and Topical Biomedics, Inc.

U.S. Topical Pain Relief Market
By Type

Your browser does not support the canvas element.

Prescription Pain Relief segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the U.S. topical pain relief market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers U.S. topical pain relief market analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of factors that drive and restrain the growth of the U.S. topical pain relief market is provided. 
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and U.S. Topical pain relief Market growth.


Key Market Segments

  • By Therapeutic Class
    • Non-opioids
      • Nonsteroidal anti-inflammatory drug (NSAIDS)
      • Methyl Salicylate
      • Capsaicin
      • Lidocaine
      • Other Non-opioids
    • Opioids
      • Buprenorphine
      • Fentanyl
  • By Formulation
    • Cream
    • Gel
    • Spray
    • Patch
    • Others
  • By Type
    • Prescription Pain Relief
    • Over-the-counter (OTC) Pain Relief
  • By Distribution Channel
    • Pharmacy & Drug Store
    • E-Commerce
    • Retail & Grocery Store


Key Market Players

  • ADVACARE PHARMA
  • GLAXOSMITHKLINE PLC (GSK)
  • JOHNSON & JOHNSON
  • NESTLÉ S.A.
  • NOVARTIS AG
  • PFIZER INC.
  • RECKITT BENCKISER GROUP PLC
  • SANOFI
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • TOPICAL BIOMEDICS, INC.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five force analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in prevalence of arthritis
3.4.1.2.Growth in geriatric population
3.4.1.3.High demand for topical pain relief products by sportsperson
3.4.1.4.Lesser side effects caused by topical pain relief products as compared to oral medicines

3.4.2.Restraints

3.4.2.1.Topical pain relief sometimes cause skin irritants
3.4.2.2.Topical pain relief is characterized by unpleasant odor

3.4.3.Opportunities

3.4.3.1.Emergence of online pharmacy

3.4.4.Impact analysis

3.5.COVID-19 Impact analysis on U.S. topical pain relief market

CHAPTER 4:U.S. TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC CLASS

4.1.Overview

4.1.1.Market size and forecast

4.2.Non-opioids

4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by type

4.2.2.1.Nonsteroidal anti-inflammatory drugs (NSAIDS)

4.2.2.1.1.Market size and forecast

4.2.2.2.Methyl salicylates

4.2.2.2.1.Market size and forecast

4.2.2.3.Capsaicin

4.2.2.3.1.Market size and forecast

4.2.2.4.Lidocaine

4.2.2.4.1.Market size and forecast

4.2.2.5.Other non-opioids

4.2.2.5.1.Market size and forecast

4.3.Opioids

4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Buprenorphine

4.3.2.1.1.Market size and forecast

4.3.2.2.Fentanyl

4.3.2.2.1.Market size and forecast

CHAPTER 5:U.S. TOPICAL PAIN RELIEF MARKET, BY FORMULATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Cream

5.2.1.Market size and forecast

5.3.Gel

5.3.1.Market size and forecast

5.4.Spray

5.4.1.Market size and forecast

5.5.Patch

5.5.1.Market size and forecast

5.6.Others

5.6.1.Market size and forecast

CHAPTER 6:U.S. TOPICAL PAIN RELIEF MARKET, BY TYPE

6.1.Overview

6.1.1.Market size and forecast

6.2.Prescription pain relief

6.2.1.Market size and forecast

6.3.Over-the-counter pain relief

6.3.1.Market size and forecast

CHAPTER 7:U.S. TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL

7.1.Overview

7.1.1.Market size and forecast

7.2.Pharmacies & drug stores

7.2.1.Market size and forecast

7.3.E-Commerce

7.3.1.Market size and forecast

7.4.Retail & grocery stores

7.4.1.Market size and forecast

CHAPTER 8:COMPANY PROFILES

8.1.ADVACARE PHARMA

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product Portfolio

8.2.GLAXOSMITHKLINE PLC (GSK)

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.JOHNSON & JOHNSON

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.NESTLÉ S.A.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product Portfolio
8.4.5.Business performance

8.5.NOVARTIS AG

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.PFIZER INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.RECKITT BENCKISER GROUP PLC

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product Portfolio
8.7.5.Business performance

8.8.SANOFI

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.SUN PHARMACEUTICAL INDUSTRIES LTD.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio

8.9.5.Business performance

8.10.TOPICAL BIOMEDICS, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product Portfolio

LIST OF TABLES

TABLE 01.U.S. TOPICAL PAIN RELIEF MARKET, BY THERAPEUTIC CLASS, 2019–2027 ($MILLION)
TABLE 02.U.S. TOPICAL NON-OPIOIDS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.U.S. TOPICAL OPIOIDS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.U.S. TOPICAL PAIN RELIEF MARKET, BY FORMULATION, 2019–2027 ($MILLION)
TABLE 05.U.S. TOPICAL PAIN RELIEF MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.U.S. TOPICAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 07.ADVACARE: COMPANY SNAPSHOT
TABLE 08.ADVACARE: BUSINESS SEGMENTS
TABLE 09.ADVACARE: PRODUCT PORTFOLIO
TABLE 10.GSK: COMPANY SNAPSHOT
TABLE 11.GLAXOSMITHKLINE PLC.: OERATING SEGMENT
TABLE 12.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 13.GSK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 14.J&J: COMPANY SNAPSHOT
TABLE 15.J&J: OPERATING SEGMENTS
TABLE 16.J&J: PRODUCT PORTFOLIO
TABLE 17.NESTLÉ: COMPANY SNAPSHOT
TABLE 18.NESTLÉ: OPERATING SEGMENTS
TABLE 19.NESTLÉ: PRODUCT PORTFOLIO
TABLE 20.NOVARTIS: COMPANY SNAPSHOT
TABLE 21.NOVARTIS: OPERATING SEGMENT
TABLE 22.NOVARTIS: PRODUCT PORTFOLIO
TABLE 23.PFIZER: COMPANY SNAPSHOT
TABLE 24.PFIZER: OPERATING SEGMENT
TABLE 25.PFIZER: PRODUCT PORTFOLIO
TABLE 26.RB: COMPANY SNAPSHOT
TABLE 27.RB: OPERATING SEGMENTS
TABLE 28.RB: PRODUCT PORTFOLIO
TABLE 29.SANOFI: COMPANY SNAPSHOT
TABLE 30.SANOFI: OPERATING SEGMENT
TABLE 31.SANOFI: PRODUCT PORTFOLIO
TABLE 32.SUN PHARMA: COMPANY SNAPSHOT
TABLE 33.SUN PHARMA: OPERATING SEGMENTS
TABLE 34.SUN PHARMA: PRODUCT PORTFOLIO
TABLE 35.TOPICAL BIOMEDICS: COMPANY SNAPSHOT
TABLE 36.TOPICAL BIOMEDICS: OPERATING SEGMENTS
TABLE 37.TOPICAL BIOMEDICS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.U.S. TOPICAL PAIN RELIEF MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.HIGH THREAT OF SUBSTITUTES
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.NUMBER OF ELDERLY POPULATION (ADULT 65+) IN THE U.S., 2020-2060 (MILLION)
FIGURE 09.IMPACT ANALYSIS: U.S. TOPICAL PAIN RELIEF MARKET
FIGURE 10.U.S. TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, 2019–2027 ($MILLION)
FIGURE 11.U.S. TOPICAL METHYL SALICYLATES MARKET, 2019–2027 ($MILLION)
FIGURE 12.U.S. TOPICAL CAPSAICIN MARKET, 2019–2027 ($MILLION)
FIGURE 13.U.S. TOPICAL LIDOCAINE MARKET, 2019–2027 ($MILLION)
FIGURE 14.U.S. TOPICAL OTHER NON-OPIOIDS MARKET, 2019–2027 ($MILLION)
FIGURE 15.U.S. TOPICAL BUPRENORPHINE MARKET, 2019–2027 ($MILLION)
FIGURE 16.U.S. TOPICAL FENTANYL MARKET, 2019–2027 ($MILLION)
FIGURE 17.U.S. TOPICAL PAIN RELIEF CREAM MEDICATIONS MARKET, 2019–2027 ($MILLION)
FIGURE 18.U.S. TOPICAL PAIN RELIEF GEL MARKET, 2019–2027 ($MILLION)
FIGURE 19.U.S. TOPICAL PAIN RELIEF SPRAY MARKET, 2019–2027 ($MILLION)
FIGURE 20.U.S. TOPICAL PAIN RELIEF PATCH MARKET, 2019–2027 ($MILLION)
FIGURE 21.U.S. OTHERS TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 22.U.S. PRESCRIPTION PAIN RELIEF TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 23.U.S. PHARMACIES & DRUG STORES TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 24.U.S. E-COMMERCE TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 25.U.S. RETAIL & GROCERY STORES TOPICAL PAIN RELIEF MARKET, 2019–2027 ($MILLION)
FIGURE 26.GSK: NET SALES, 2017–2019 ($MILLION)
FIGURE 27.GSK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 28.GSK: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 29.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 31.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 32.NESTLÉ: REVENUE, 2017–2019 ($MILLION)
FIGURE 33.NESTLÉ: REVENUE SHARE BY OPERATING SEGMENT, 2019 (%)
FIGURE 34.NESTLÉ.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.NOVARTIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.NOVARTIS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 37.NOVARTIS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 38.PFIZER: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.PFIZER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.PFIZER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.RB: REVENUE, 2017–2019 ($MILLION)
FIGURE 42.RB: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.RB: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 44.SANOFI.: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 46.SANOFI: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 47.SUN PHARMA: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.SUN PHARMA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 49.SUN PHARMA: REVENUE SHARE BY REGION, 2019 (%)

 
 

Pain is the most prominent symptom of musculoskeletal conditions; thus, effective pain treatment is necessary. Topical pain relief products are medications that are directly rubbed onto the skin over the painful body part. These medications are available as prescription drugs or as over the counter medication. These products include creams, lotions, patches, or sprays that are applied to the skin to relieve pain from sore muscles and arthritis. Topical pain relief products use several active ingredients, such as menthol, camphor, capsaicin, and others, to relieve pain. 

Rise in patients suffering from bone pain conditions such as osteoarthritis and diabetic neuropathy, especially the geriatric population, is the major factor that drives the growth of the U.S. topical pain relief market. Other factors such as rise in demand for pain relief products by sports persons, increase in geriatric population, easy availability of the drugs, higher healthcare awareness, and less side effects caused due to topical pain relief as compared to oral medications are expected to have a significant impact on the growth of the market. However, factors such as topical pain relief products cause irritated skin and are usually characterized by unpleasant odor, which is further expected to hamper the market growth.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of U.S. Topical Pain Relief Market is $2,612.13 million in 2019.

A. The forcast period for U.S. Topical Pain Relief Market is 2019 to 2027

A. The market value of U.S. Topical Pain Relief Marketin 2020 is $2,536.49 million .

A. The base year is 2019 in U.S. Topical Pain Relief Market

A. Top companies such as GlaxoSmithKline plc, Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., and AdvaCare Pharma held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in U.S.

A. Non-opioids segment is the most influencing segment owing to lesser side effects as compared to opioids and no substance abuse, thus, non-opioids are preferably used as topical pain relief medication.

A. Increase in prevalence of arthritis and joint pain is the major factor that contributes toward the growth of the topical pain relief market in the U.S. Moreover, other factors that fuel the market growth include growth in geriatric population, lesser side effects caused due to use of topical analgesics as compared to oral pain relief, wide availability of topical pain relieving drugs, and high demand for topical pain relief by sports players.

A. No, there is no value chain analysis provided in the U.S. Topical Pain Relief Market report

A. Topical pain relief medications are pain killers that are directly applied, rubbed, or sprayed on the skin over painful muscles or joints

A. Topical Pain Relief are used to relieve pain as they are composed of different ingredients such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDS), salicylates, capsaicin, and others. These products have a heating or cooling effect that stimulate the nerves near the pain point and relieve pain.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
U.s. Topical Pain Relief Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Data Pack
  • $2,180
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $3,448
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $3,662
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $6,107
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers